Back to PathoKing

Acute Leukaemia module

Acute Leukaemia

Trace clonal blast expansion through marrow failure, tissue infiltration, tumour lysis, diagnosis, and urgent subtype-directed treatment.

advanced35 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Acute Leukaemia?

Different triggers converge on the condition's central pathological process.

De novo driver alterations

Typical setting: Somatic mutations or rearrangements arise in a haematopoietic progenitor.

Cooperating lesions impair differentiation and increase self-renewal.

Antecedent marrow disease

Typical setting: Myelodysplasia or a myeloproliferative neoplasm acquires additional drivers.

Clonal evolution transforms chronic ineffective haematopoiesis into acute blast proliferation.

Therapy-related disease

Typical setting: Prior cytotoxic chemotherapy or radiation damages progenitor DNA.

Selected clones with characteristic genetic abnormalities may emerge years later.

Inherited susceptibility

Typical setting: Down syndrome and germline DNA-repair or marrow-failure syndromes raise risk.

Constitutional genomic instability lowers the threshold for malignant transformation.

Specific fusion events

Typical setting: PML-RARA in acute promyelocytic leukaemia or BCR-ABL1 in some ALL creates a distinct biology.

The altered protein becomes both a disease driver and a treatment target.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

A progenitor acquires cooperating drivers

Self-renewal rises and normal maturation is blocked.

2

Blasts expand in marrow

The malignant clone progressively occupies haematopoietic space and resources.

Checking account access...